SARS-CoV-2 Variants in COVID-19 Disease: A Focus on Disease Severity and Vaccine Immunity in Patients Admitted to the Emergency Department
Authors:
- Marta FogolariMFMarta Fogolari
- Maria FrancesconiMFMaria Francesconi
- Lucia De FlorioLFLucia De Florio
- Marta GiovanettiMarta Giovanetti
- Roberta VeralliRVRoberta Veralli
- Cecilia De FloraCFCecilia De Flora
- Antonello MaruottiAMAntonello Maruotti
- Fabio ScarpaFabio Scarpa
- Silvia SpotoSilvia Spoto
- Federica SambucoFSFederica Sambuco
- Elisabetta RivaERElisabetta Riva
- Massimo CiccozziMassimo Ciccozzi
Open Access
- 2 December 2022
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (12) , 2001
Abstract
Tracking SARS-CoV-2 variants along with vaccinations are fundamental for severe COVID-19 disease prevention. A study was performed that focused on 43 patients with the SARS-CoV-2 infection who were admitted to the Emergency Department. RT-PCR–positive nasopharyngeal samples were sequenced using the MiSeq II system for variant detection. The main reason for Emergency Department admission was COVID-19 (67%), followed by other causes (33%); 51% patients were unvaccinated or vaccinated with a single dose and 49% had completed the vaccination course with two or three doses. Among the vaccinated group, 38% were admitted for COVID-19, versus 94.5% of the unvaccinated group. After admission, 50% of the vaccinated group and 36% of the unvaccinated group were discharged and allowed to go home, and 80% of the unvaccinated had no major comorbidities; 63% needed hospital admission and 5% required a stay in the Intensive Care Unit. Of these, 37% were vaccinated with 3 doses, 11% with two doses, 4% with a single dose, and 48% were unvaccinated. The 70% of the vaccinated patients who were admitted to hospital presented major comorbidities versus 38% of the unvaccinated group. Two unvaccinated patients that needed intensive care had relevant comorbidities and died. Genome sequencing showed the circulation of three omicron and two pure sub-lineages of omicron, including 22 BA.1, 12 BA.1.1, and 7 BA.2. Data showed the SARS-CoV-2 national and international migration patterns and how vaccination was useful for severe COVID-19 disease prevention.Keywords
Funding Information
- PON “Ricerca e Innovazione” (2014–2020)
This publication has 21 references indexed in Scilit:
- Detection of highly muted coronavirus variant Omicron (B.1.1.529) is triggering the alarm for South Asian countries: Associated risk factors and preventive actionsJournal of Medical Virology, 2021
- Odds of Testing Positive for SARS-CoV-2 Following Receipt of 3 vs 2 Doses of the BNT162b2 mRNA VaccineJAMA Internal Medicine, 2021
- Antibody Responses to COVID-19 Vaccination in Cancer: A Systematic ReviewFrontiers in Oncology, 2021
- Protection of BNT162b2 Vaccine Booster against Covid-19 in IsraelNew England Journal of Medicine, 2021
- The biological and clinical significance of emerging SARS-CoV-2 variantsNature Reviews Genetics, 2021
- The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemicCurrent Biology, 2021
- SARS-CoV-2 variants and ending the COVID-19 pandemicThe Lancet, 2021
- A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiologyNature Microbiology, 2020
- An integrated national scale SARS-CoV-2 genomic surveillance networkThe Lancet Microbe, 2020
- An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVarGenome Biology, 2019